676
Views
3
CrossRef citations to date
0
Altmetric
Diagnostics

Diagnostic comparison of methacholine and mannitol bronchial challenge tests for identifying bronchial hyperresponsiveness in asthma: a systematic review and meta-analysis

, MD, PhDORCID Icon & , MD, PhDORCID Icon
Pages 883-891 | Received 22 Sep 2019, Accepted 04 Mar 2020, Published online: 16 Mar 2020

References

  • National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program: Expert panel report III: guidelines for the diagnosis and management of asthma. [accessed 2020 Jan 28]. https://www.nhlbi.nih.gov/files/docs/guidelines/asthgdln.pdf.
  • Cockcroft DW. Direct challenge tests: airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest. 2010;138(2):18S–24S. doi:10.1378/chest.10-0088.
  • Anderson SD. Indirect challenge tests: airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest. 2010;138(2):25S–30S. doi:10.1378/chest.10-0116.
  • Anderson SD, Brannan J, Spring J, Spalding N, Rodwell LT, Chan K, Gonda I, Walsh A, Clark AR. A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med. 1997;156(3):758–65. doi:10.1164/ajrccm.156.3.9701113.
  • McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM, Clifford T, Cohen JF, Deeks JJ, Gatsonis C, Hooft L, et al. Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. JAMA. 2018;319(4):388–96. doi:10.1001/jama.2017.19163.
  • Global Initiative Asthma. Global strategy for asthma managment and prevention (2012). [accessed 2020 Jan 28]. https://www.nhlbi.nih.gov/health-topics/guidelines-for-diagnosis-management-of-asthma.
  • Coates AL, Wanger J, Cockcroft DW, Culver BH, Carlsen K-H, Diamant Z, Gauvreau G, Hall GL, Hallstrand TS, Horvath I, et al. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J. 2017;49(5):1601526. doi:10.1183/13993003.01526-2016.
  • Hallstrand TS, Leuppi JD, Joos G, Hall GL, Carlsen KH, Kaminsky DA, Coates AL, Cockcroft DW, Culver BH, Diamant Z, et al. ERS technical standard on bronchial challenge testing: pathophysiology and methodology of indirect airway challenge testing. Eur Respir J. 2018;52(5):1801033. doi:10.1183/13993003.01033-2018.
  • Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3(1):25. doi:10.1186/1471-2288-3-25.
  • Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005;58(10):982–90. doi:10.1016/j.jclinepi.2005.02.022.
  • Thompson SG. Why sources of heterogeneity in meta-analysis should be investigated. BMJ. 1994;309:1351–5. doi:10.1136/bmj.309.6965.1351.
  • Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, Bossuyt PM. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA. 1999;282(11):1061–6. doi:10.1001/jama.282.11.1061.
  • Aronsson D, Tufvesson E, Bjermer L. Comparison of central and peripheral airway involvement before and during methacholine, mannitol and eucapnic hyperventilation challenges in mild asthmatics. Clin Respir J. 2011;5(1):10–8. doi:10.1111/j.1752-699X.2009.00183.x.
  • Cancelliere N, Bobolea I, Lopez-Carrasco V, Barranco P, Lopez-Serrano C, Quirce S. Comparative study of bronchial hyperresponsiveness to methacholine and mannitol in the initial diagnosis of asthma. J Investig Allergol Clin Immunol. 2013;23:361–2.
  • Kim MH, Song WJ, Kim TW, Jin HJ, Sin YS, Ye YM, Kim SH, Park HW, Lee BJ, Park HS, et al. Diagnostic properties of the methacholine and mannitol bronchial challenge tests: a comparison study. Respirology. 2014;19(6):852–6. doi:10.1111/resp.12334.
  • Porpodis K, Domvri K, Kontakiotis T, Fouka E, Kontakioti E, Zarogoulidis K, Papakosta D. Comparison of diagnostic validity of mannitol and methacholine challenges and relationship to clinical status and airway inflammation in steroid-naive asthmatic patients. J Asthma. 2017;54(5):520–9. doi:10.1080/02770903.2016.1238926.
  • Sue-Chu M, Brannan JD, Anderson SD, Chew N, Bjermer L. Airway hyperresponsiveness to methacholine, adenosine 5-monophosphate, mannitol, eucapnic voluntary hyperpnoea and field exercise challenge in elite cross-country skiers. Br J Sports Med. 2010;44(11):827–32. doi:10.1136/bjsm.2009.071043.
  • Sverrild A, Porsbjerg C, Thomsen SF, Backer V. Airway hyperresponsiveness to mannitol and methacholine and exhaled nitric oxide: a random-sample population study. J Allergy Clin Immunol. 2010;126(5):952–8. doi:10.1016/j.jaci.2010.08.028.
  • Kernen P, Steveling-Klein EH, Saccilotto RT, Raatz H, Briel M, Koller MT, Westwood M, Bucher HC, Miedinger D, Leuppi JD. The sensitivity and specificity of the mannitol bronchial challenge test to identify asthma in different populations: a systematic review. Swiss Med Wkly. 2019;149:w20100. doi:10.4414/smw.2019.20100.
  • Anderson SD, Brannan JD. Bronchial provocation testing: the future. Curr Opin Allergy Clin Immunol. 2011;11(1):46–52. doi:10.1097/ACI.0b013e3283423183.
  • Sumino K, Sugar EA, Irvin CG, Kaminsky DA, Shade D, Wei CY, Holbrook JT, Wise RA, Castro M. Methacholine challenge test: diagnostic characteristics in asthmatic patients receiving controller medications. J Allergy Clin Immunol. 2012;130(1):69–75.e6. doi:10.1016/j.jaci.2012.02.025.
  • Chinn S, Jarvis D, Luczynska CM, Ackermann-Liebrich U, Anto JM, Cerveri I, de Marco R, Gislason T, Heinrich J, Janson C, et al. An increase in bronchial responsiveness is associated with continuing or restarting smoking. Am J Respir Crit Care Med. 2005;172(8):956–61. doi:10.1164/rccm.200503-323OC.
  • Britton J, Pavord I, Richards K, Knox A, Wisniewski A, Wahedna I, Kinnear W, Tattersfield A, Weiss S. Factors influencing the occurrence of airway hyperreactivity in the general population: the importance of atopy and airway calibre. Eur Respir J. 1994;7(5):881–7.
  • Sunyer J, Anto JM, Kogevinas M, Soriano JB, Tobias A, Munoz A. Smoking and bronchial responsiveness in nonatopic and atopic young adults. Spanish Group of the European Study of Asthma. Thorax. 1997;52(3):235–8. doi:10.1136/thx.52.3.235.
  • Porsbjerg C, Brannan JD, Anderson SD, Backer V. Relationship between airway responsiveness to mannitol and to methacholine and markers of airway inflammation, peak flow variability and quality of life in asthma patients. Clin Exp Allergy. 2008;38:43–50. doi:10.1111/j.1365-2222.2007.02878.x.
  • White EC, de Klerk N, Hantos Z, Priston M, Hollams EM, James A, Sly PD, Holt PG, Hall GL. Mannitol challenge testing for asthma in a community cohort of young adults. Respirology. 2017;22(4):678–83. doi:10.1111/resp.12955.
  • de Menezes MB, Ferraz E, Brannan JD, Martinez EZ, Vianna EO. The efficacy and safety of mannitol challenge in a workplace setting for assessing asthma prevalence. J Asthma. 2018;55(12):1278–85. doi:10.1080/02770903.2017.1418887.
  • Knag Pedersen S, Ustrup AS, Baarnes CB, Suppli Ulrik C. Usefulness of mannitol challenge testing for diagnosing asthma in everyday clinical practice. J Asthma. 2019;1–7. doi:10.1080/02770903.2019.1600144.
  • Andregnette-Roscigno V, Fernandez-Nieto M, Del Potro MG, Aguado E, Sastre J. Methacholine is more sensitive than mannitol for evaluation of bronchial hyperresponsiveness in children with asthma. J Allergy Clin Immunol. 2010;126(4):869–71. doi:10.1016/j.jaci.2010.07.025.
  • Andregnette-Roscigno V, Fernandez-Nieto M, Arochena L, Garcia Del Potro M, Aguado E, Sastre J. Methacholine is more sensitive than mannitol for evaluation of bronchial hyper-responsiveness in youth athletes with exercise-induced bronchoconstriction. Pediatr Allergy Immunol. 2012;23(5):501–3. doi:10.1111/j.1399-3038.2012.01293.x.
  • Dinnes J, Deeks J, Kirby J, Roderick P. A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy. Health Technol Assess. 2005;9(12):1–113, iii. doi:10.3310/hta9120.
  • Brannan JD, Koskela H, Anderson SD, Chan HK. Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects. Respirology. 2002;7(1):37–44. doi:10.1046/j.1440-1843.2002.00357.x.
  • Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ, Green RH. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178(3):218–24. doi:10.1164/rccm.200711-1754OC.
  • Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, D’Agostino R, Castro M, Curran-Everett D, Fitzpatrick AM, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010;181(4):315–23. doi:10.1164/rccm.200906-0896OC.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.